| Accession |
PRJCA015060 |
| Title |
Single- and Multiple-Dose Pharmacokinetics of BMS-986165 in a Randomized, Double-Blind, Placebo-Controlled Study in Healthy Chinese Subjects |
| Relevance |
Medical |
| Data types |
Metabolic data
|
| Organisms |
Homo sapiens
|
| Description |
The present study is being conducted to evaluate the pharmacokinetics (PK), safety and tolerability of BMS-986165 administered at single and multiple once daily (QD) oral doses in healthy Chinese subjects. |
| Sample scope |
Multiisolate |
| Release date |
2023-02-19 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Bristol-Myers Squibb (China) Investment Co., Ltd., Bristol-Myers Squibb Company
|
|
JXHL1800147/JXHL1800146
|
|
|
|
| Submitter |
YANG
LIN (linyang@anzhengcp.com)
|
| Organization |
Beijing Anzhen Hospital, Capital Medical University |
| Submission date |
2023-02-19 |
